TipRanks
Go Ultimate55% OFF

Zivo Bioscience (ZIVO) Ownership - Who Owns Zivo Bioscience?

Zivo Bioscience (ZIVO) Ownership Overview

  • 50.75% Insiders
  • 0.01% Other Institutional Investors
  • 49.24% Public Companies and Individual Investors

The ownership structure of Zivo Bioscience (ZIVO) stock is a mix of institutional, retail, and individual investors. Approximately 0.01% of the company’s stock is owned by Institutional Investors, 50.75% is owned by Insiders, and 49.24% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Apr 23, 2026Mark E Strome$200,000
Feb 16, 2026Mark E Strome$195,400
Feb 11, 2026Laith L Yaldoo$24,997
Jan 27, 2026Alison Cornell$99,995

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

ZIVO top shareholders
Holder# of SharesType% HoldingValue
Laith L Yaldoo582,072Insider14.97%4,726,425
Mark E Strome572,942Insider14.73%4,652,289
Christopher D. Maggiore519,292Insider13.35%4,216,651
Alison Cornell279,481Insider7.19%2,269,386
John Bernard Payne19,618Insider0.50%159,298

FAQ

Who Owns Zivo Bioscience (ZIVO)?
According to the latest TipRanks data, approximately 0.01% of the company's stock is held by institutional investors, 50.75% is held by insiders, and 49.24% is held by retail investors.
What percentage of Zivo Bioscience (ZIVO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.01% of Zivo Bioscience (ZIVO) stock is held by institutional investors.
What percentage of Zivo Bioscience (ZIVO) stock is held by retail investors?
According to the latest TipRanks data, approximately 49.24% of Zivo Bioscience (ZIVO) stock is held by retail investors.
Who owns the most shares of Zivo Bioscience (ZIVO)?
LAITH L YALDOO owns the most shares of Zivo Bioscience (ZIVO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.